PofoliaShared via Pofolia

Genome Medicine· 2026Q1

MaveMD: a functional data resource for genomic medicine

Abbye E. McEwen, Jeremy Stone, Malvika Tejura, Pankhuri Gupta et al.

Short summary

MaveMD is a new interface for the MaveDB database that integrates functional genetic variant data with clinical resources like ClinVar, simplifying the classification of variants of uncertain significance (VUS) for precision medicine.

AI-generated from the title and abstract; the full text is not read.

Key points

  • MaveMD integrates MAVE data with clinical resources (ClinVar, ClinGen Allele Registry) and provides clinical evidence calibrations.
  • It automatically maps MAVE datasets to the human reference genome, simplifying clinical translation.
  • A new metadata model was defined after curating 438,318 variant effect measurements from 74 MAVE datasets.
  • The interface is designed to enable effective clinical decision-making and export structured evidence for variant classification.

AI-generated from the title and abstract; the full text is not read.

Abstract

Variant interpretation remains one of the most significant challenges in clinical genetics. Variants of uncertain significance (VUS) undermine precision medicine implementation because they have an unknown relationship to disease and cannot be used for clinical decision-making. While evidence from multiplexed assays of variant effect (MAVEs) and other functional assays can help classify variants, major barriers prevent routine use in clinical variant classification, including fragmentation across multiple repositories, insufficient data standards, and the need to calibrate assays clinically. Here we address these challenges by presenting a new interface for the MaveDB database called MaveMD (MAVEs for MeDicine) that integrates with external resources such as ClinVar and the ClinGen Allele Registry, displays clinical evidence calibrations, provides intuitive visualizations, and exports structured evidence compatible with ACMG/AMP variant classification guidelines. MaveMD implements automatic mapping of MaveDB datasets to the human reference genome, dramatically simplifying the clinical translation of new MAVE data. We also defined a new metadata model after curating 438,318 variant effect measurements from 74 MAVE datasets spanning 32 disease-associated genes, and created an interface aimed at enabling effective clinical decision-making. Thus, MaveMD makes MAVE data accessible and easily usable for variant classification, and will scale seamlessly with future data generation efforts to empower the use of MAVE evidence in clinical practice.

The authors' abstract, as published at the source. Genome Medicine, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Genetics (Biochemistry, Genetics and Molecular Biology)

GeneticsBiochemistry, Genetics and Molecular Biology